A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting

BACKGROUND: Urine drug screening (UDS) is commonly used as part of treatment for opioid use disorder (OUD), including treatment with buprenorphine-naloxone for OUD in a primary care setting. Very little is known about the value of UDS, the optimum screening frequency in general, or its specific use...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobel, Halle G., Warrington, Jill S., Francis-Fath, Samuel, Crocker, Abigail M., Berger, Claudia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482571/
https://www.ncbi.nlm.nih.gov/pubmed/34593036
http://dx.doi.org/10.1186/s13722-021-00264-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482571/
https://www.ncbi.nlm.nih.gov/pubmed/34593036
http://dx.doi.org/10.1186/s13722-021-00264-4

Ejemplares similares